Background and Purpose: Hypoxia alters the responsiveness to endogenous substances of cerebral arteries, possibly resulting in the modulation of blood supply to ischemic brain regions. The present study was undertaken to analyze the mechanism of potentiation by hypoxia of angiotensin ll-induced cerebroarterial contractions.
Potentiation by Hypoxia of Contractions
Caused by Angiotensin II in Dog and Monkey Cerebral Arteries Kazuhide Yoshida, MD, PhD; Tomio Okamura, MD, PhD; and Noboru Toda, MD, PhD Background and Purpose: Hypoxia alters the responsiveness to endogenous substances of cerebral arteries, possibly resulting in the modulation of blood supply to ischemic brain regions. The present study was undertaken to analyze the mechanism of potentiation by hypoxia of angiotensin ll-induced cerebroarterial contractions.
Methods: Monkey and dog cerebral arterial strips with endothelium were suspended for isometric tension recording in Ringer-Locke solution aerated with 95% 02-5% CO2 (partial 02 pressure, 570-600 mm Hg) or 95% N2-5% CO2 (approximately 10 mm Hg).
Results: Contractions induced by angiotensin II and substance P were potentiated by exposure to hypoxia, whereas contractile responses to prostaglandin F2,, were not influenced. Treatment with cyclooxygenase inhibitors abolished the peptide-induced contraction but did not alter the prostaglandin F2a,-induced contraction. Relaxations induced by arachidonic acid were suppressed by indomethacin and hypoxia, whereas those caused by a prostaglandin I2 analogue were unaffected. Conclusions: The potentiation by hypoxia of cerebroarterial contractions caused by angiotensin II and substance P appears to be due to an interference with the synthesis of prostaglandin 12 (9, 11) , (11, 12 )-dideoxa-9,11-dimethylmethano-11,12-methano-13,14-dihydro-13-azo- Substance P (10-7 M)-induced contractions, susceptible to cyclooxygenase inhibitors,2 were also potentiated in the strips exposed to severe hypoxia, whereas the contraction induced by PGF2, was not significantly influenced ( Figure 3 ). In the strips treated with 10`M L-NA, the substance P-induced contraction was also potentiated by hypoxia. The mean value of potentiation was 52.0+8.7% (n=8,p<0.001); the difference between the values in control and L-NA-treated strips was not significantly different.
In cerebral arterial strips treated with 10`' M ON03708, which is an antagonist of vasoconstrictor PGs,'3 and contracted with serotonin, arachidonic acid (10--i0-6 M) produced a concentration-related relaxation, which was markedly inhibited by treatment with 10`6 M indomethacin (Figure 4, right panel) . Hypoxia significantly inhibited the arachidonic acid-induced relaxation ( Figure 4 , left panel). Concentration (10- tended to be increased, but the difference was not statistically significant. Typical responses are shown in Figure 6 . In the hypoxic media, as in normoxia, indomethacin markedly suppressed the response to Ang II (from 350±101 to 32+7 mg, n=3, 90.3+1.2% inhibition, p<O.OOl) but not to PGF2a.
Content of 6-Keto-PGF,a
The addition of Ang 11 (10-7 M) (Table 1) . These results indicate that the potentiation is ascribed to an increase in the production of vasoconstrictor PGs and a decrease in the release by the peptides of vasodilator substances or in the sensitivity to the vasodilators but not to the increased responsiveness to PGs. Reductions by hypoxia of the release of vasodilator prostanoids are postulated in sheep pulmonary arteries.'6 Relaxations induced by arachidonic acid (10-7 M) in dog cerebral arteries were abolished by 10-6 M indomethacin (Figure 4 , right panel), suggesting the involvement of vasodilator PGs, possibly PGI2. In the cerebral arterial strips, only PGI2 produces relaxation among the cyclooxygenase products used. [17] [18] [19] In the arteries treated with ON03708, the action of arachidonic acid was suppressed by hypoxia.
Relaxant responses to beraprost, a stable PGI2 analogue,20 were not influenced by hypoxia. These findings suggest an inhibition by hypoxia of the PGI2 synthesis.
Therefore, it appears that the potentiating effect of hypoxia on the contractile response to Ang II and substance P is due to an interference with the production of PGI2 from arachidonic acid that would be liberated from activation of the peptide receptors. In fact, the content of 6-keto-PGF1a in bathing media, in which the arterial strips were stimulated by Ang II, was markedly reduced by hypoxia, suggesting a depression of PGI2 synthesis. The 
